Sp1102
TRAINING AND COMPETENCY IN EMR: HOW DO WE KNOW WHO'S COMPETENT?
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
Get an update on the leading controversies in therapeutic endoscopy in 2023 including disposable endoscopes, endoscopic resection, competency in EMR, cholangioscopy, and endoscopic sleeve gastrectomy. LIVE STREAM SESSION
Get an update on the leading controversies in therapeutic endoscopy in 2023 including disposable endoscopes, endoscopic resection, competency in EMR, cholangioscopy, and endoscopic sleeve gastrectomy. LIVE STREAM SESSION
Presenter
University of Virginia
Tracks
Related Products
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMIS-UC, COHORT 1
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PANEL DISCUSSION
Get an update on the leading controversies in therapeutic endoscopy in 2023 including disposable endoscopes, endoscopic resection, competency in EMR, cholangioscopy, and endoscopic sleeve gastrectomy…
